Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

CUSIP: 55234L105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
1,644,695
Total 13F shares
7,037,339
Share change
+7,037,339
Total reported value
$79,798,000
Price per share
$11.34
Number of holders
43
Value change
+$79,798,000
Number of buys
43

Quarterly Holders Quick Answers

What is CUSIP 55234L105?
CUSIP 55234L105 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q2 2020

As of 30 Jun 2020, Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,037,339 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, BlackRock Inc., Invesco Ltd., ArrowMark Colorado Holdings LLC, PURA VIDA INVESTMENTS, LLC, BANK OF AMERICA CORP /DE/, and ALLIANCEBERNSTEIN L.P.. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.